UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 24, 2009
EnzymeBioSystems
------------------------------------------------
(Name of Small Business Issuer in its Charter)
Nevada 333-160649 27-0464302
---------------------------- ------------ ------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
35595 Spatterdock Lane, Solon, OH 44139
--------------------------------------------------------------------
(Address of principal executive offices)
(440) 554-5417
---------------------------
(Issuer's telephone number)
Not Applicable.
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions (see General Instruction A.2. below):
[_] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
=============================================================================
1
ITEM 4.01 CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
(a) Dismissal of Moore & Associates, Chartered
On August 24, 2009 (the "Dismissal Date"), the Board of Directors of
EnzymeBioSystems (the "Registrant") dismissed Moore & Associates, Chartered,
its independent registered public accounting firm.
The audit report of Moore & Associates, Chartered on the audited
financial statements of the Registrant for the period from inception on
June 26, 2009 to the fiscal year ended June 30, 2009, did not contain any
adverse opinion or disclaimer of opinion, nor were they qualified or
modified as to uncertainty, audit scope or accounting principles, except a
going concern qualification in its July 7, 2009 Audit Report of the
Registrant's financial statements for the fiscal year ended June 30, 2009,
as contained in its Form S-1 Registration Statement.
During the Registrant's most recent fiscal year and through the Dismissal
Date, there were no disagreements (as defined in Item 304 of Regulation S-K)
with Moore & Associates, Chartered on any matter of accounting principles or
practices, financial statement disclosure, or auditing scope or procedure,
which disagreements, if not resolved to the satisfaction of Moore &
Associates, Chartered, would have caused it to make reference in connection
with its opinion to the subject matter of the disagreement. Further, during
the Registrant's most recent fiscal year and through the Dismissal Date,
there were no reportable events (as defined in Item 304(a)(1)(v) of
Regulation S-K).
The Registrant provided Moore & Associates, Chartered with a copy of this
Report prior to its filing with the Securities and Exchange Commission (the
"SEC") and requested Moore & Associates, Chartered to furnish the Registrant
with a letter addressed to the SEC, stating whether or not it agrees with the
statements made above and, if not, stating the respects in which they do not
agree. A copy of such letter, dated August 24, 2009, is filed as Exhibit
16.1 to this Report.
(b) Engagement of Seale and Beers, CPAs
On August 24, 2009 (the "Engagement Date"), the Registrant's Board of
Directors approved the appointment of Seale and Beers, CPAs as the
Registrant's independent registered public accounting firm. During the
Registrant's most recent fiscal year and through the Engagement Date, neither
the Registrant nor anyone on its behalf consulted the Current Accountants
regarding either (1) the application of accounting principles to a specified
transaction regarding the Company, either completed or proposed, or the type
of audit opinion that might be rendered on the Company's financial
statements; or (2) any matter regarding the Company that was either the
subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K
and related instructions to Item 304 of Regulation S-K) or a reportable event
(as defined in Item 304(a)(1)(v) of Regulation S-K).
2
ITEM 9.01 FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
c) Exhibits
No. Exhibits
--- --------
16.1 Letter from Moore and Associates, Chartered, dated
August 24, 2009, to the Securities and Exchange Commission
regarding statements included in this Form 8-K.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
EnzymeBioSystems
----------------------
Registrant
/s/ Anushavan Yeranosyan
Dated: August 24, 2009 ---------------------------------
--------------- By: Anushavan Yeranosyan
Its: Director, Secretary,
Treasurer, Chief Financial
and Accounting Officer
3